ORTEXORTEX News
Tracking CBRS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CB
Trader NoteCBRS

CBRS Options Signal Caution as Shorts Rebuild After Earnings Drop

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 22 Jul 2026, 20:35

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Cerebras Systems enters the second half of July in a genuinely interesting position: the stock just jumped 18% in a single session, yet options traders are more defensively positioned than at almost any point in the past year — and short sellers have been quietly rebuilding since a post-earnings selloff.

The clearest tension sits in options. The put/call ratio has climbed to 0.81, more than two standard deviations above its 20-day mean of 0.64 — the second-highest defensive reading recorded in the past year, with only the 52-week peak of 0.92 topping it. That jump coincided with the stock's 18% single-day rally on July 21, suggesting investors moved quickly to hedge gains rather than chase them. The defensive posture looks reactive rather than pre-emptive, but it remains elevated enough to be worth noting.

The lending market tells a story of gradual loosening after a period of extreme tightness. Through most of June and into early July, borrow availability was effectively zero — every share in the lending pool lent out, with utilisation hitting 100% across multiple consecutive sessions. That picture has eased materially: availability has recovered to roughly 11.5% now, and the cost to borrow has dropped from a peak near 4.2% in late June to below 2% this week. Short interest in raw share terms has crept up about 4% on the week and 19% over the past month to approximately 11.7 million shares, though the absence of a reliable free-float figure makes a precise percentage calculation unavailable. What is clear is that shorts were not squeezed out — they appear to have rebuilt steadily once borrow came back online. The ORTEX short score of 67.5 is consistent with a name carrying meaningful short-side conviction.

The analyst community is broadly constructive, but the Street's enthusiasm has been stress-tested by the June earnings reaction. After Q1 results on June 23, the stock fell nearly 19% on the day before recovering almost all of that loss within the following week. Most analysts held or lifted targets in the wake of that print: UBS raised to $320, Morgan Stanley moved to $273, Wedbush nudged to $280, while Needham and Rosenblatt both held at $300 and $275 respectively. The one outlier came from Freedom Capital Markets, which initiated with a Hold at $209 — almost exactly where the stock trades today at $208.57. The consensus remains Buy, with a mean target of $291, implying meaningful return potential from current levels. Bulls point to Cerebras's wafer-scale architecture and momentum in sovereign and enterprise AI workloads. Bears flag the customer concentration risk — OpenAI and AWS together represent a substantial portion of revenue — and warn that the current growth trajectory may compress as competition from established GPU vendors intensifies. The valuation is not cheap: the stock changed hands today at a price-to-book of roughly 7.8x, and the price-to-earnings multiple is in the thousands, reflecting near-zero current profitability against high growth expectations.

Ownership is concentrated among early-stage backers and a handful of institutional names. FMR (Fidelity) added a significant position as of June 30, reporting 28.8 million shares — the largest single institutional holder. CEO-adjacent and insider flows lean net positive over the past 90 days in aggregate, though the COO, Dhiraj Mallick, sold shares on multiple occasions in late June at prices between $162 and $207, and the Chief Accounting Officer trimmed modest amounts in the same window. The trades carry low significance scores and look consistent with planned disposals rather than a change in fundamental outlook.

The next earnings event is scheduled for September 22. Given that the last two prints produced a combined pattern of a sharp single-day drop followed by a full recovery within five days, the setup heading into that date — how far the stock has run, whether availability tightens again, and whether the put/call ratio sustains its elevated level — will be the metrics to track between now and then.

Stocks in this article

See the live data behind this article on ORTEX.

Open CBRS on ORTEX →

How this article was generated

Generated
22 Jul 2026, 20:43
Data as of
22 Jul 2026, 20:35
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.